News
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

Looking for jobs? Search jobs

124,538 Results

Type

Article (4233)
Company Profile (93)
Press Release (120212)

Section

Business (41971)
Career Advice (206)
Deals (6148)
Drug Delivery (12)
Drug Development (17351)
Employer Resources (18)
FDA (1481)
Job Trends (2769)
News (65948)
Policy (3639)

Tag

Date

Today (44)
Last 7 days (184)
Last 30 days (592)
Last 365 days (9436)
2024 (6600)
2023 (9883)
2022 (11997)
2021 (12645)
2020 (9850)
2019 (6675)
2018 (5277)
2017 (6076)
2016 (5592)
2015 (6439)
2014 (4922)
2013 (4060)
2012 (4397)
2011 (4870)
2010 (4514)

Filters

Type

Article (4233)
Company Profile (93)
Press Release (120212)

Section

Business (41971)
Career Advice (206)
Deals (6148)
Drug Delivery (12)
Drug Development (17351)
Employer Resources (18)
FDA (1481)
Job Trends (2769)
News (65948)
Policy (3639)

Tag

Date

Today (44)
Last 7 days (184)
Last 30 days (592)
Last 365 days (9436)
2024 (6600)
2023 (9883)
2022 (11997)
2021 (12645)
2020 (9850)
2019 (6675)
2018 (5277)
2017 (6076)
2016 (5592)
2015 (6439)
2014 (4922)
2013 (4060)
2012 (4397)
2011 (4870)
2010 (4514)

124,538 Results for "novome biotechnologies".

Sort By

Pharm Country

Colorcon Ventures Invests in Novome Biotechnologies, an Engineered Microbial Therapy Company

Colorcon Ventures, the corporate venture fund of Colorcon Inc., has invested in Novome Biotechnologies, a clinical-stage company that develops engineered oral microbial therapies.

September 15, 2022
·
2 min read
Business

Novome Biotechnologies Appoints Bill McLeod as Chief Financial Officer

Novome Biotechnologies, Inc. today announced the appointment of Bill McLeod as Chief Financial Officer.

October 20, 2021
·
2 min read
Business

Novome Biotechnologies and Genentech Enter into a Strategic Collaboration to Develop Targets Against Inflammatory Bowel Disease

Novome Biotechnologies, Inc., a clinical-stage biotechnology company developing engineered cellular therapies for the gut, today announced a multi-year research collaboration and licensing agreement with Genentech.

November 10, 2021
·
3 min read
Drug Development

Novome Biotechnologies Reports Positive Results from a Phase 1 Study of NOV-001

Novome Biotechnologies, Inc., a clinical-stage biotechnology company developing engineered cellular therapies for the gut, today announced positive results from a Phase 1 study of orally-administered NOV-001 in healthy volunteers.

November 17, 2021
·
5 min read
Business

Novome Biotechnologies Appoints Dr. Lachy McLean as Chief Medical Officer

Novome Biotechnologies, Inc. today announced the appointment of Lachy McLean, MBChB, PhD, as Chief Medical Officer.

June 22, 2021
·
3 min read
Deals

Arbor Biotechnologies Announces Acquisition of Serendipity

Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, announced the acquisition of Serendipity Biosciences, a private biotechnology company focused on the discovery of unique gene editing technologies.

May 8, 2024
·
3 min read
BioMidwest

Anbio Biotechnology to Showcase at ADLM 2024 with Evolved In Vitro Diagnostic Solutions

Anbio Biotechnology (“Anbio”), a leading global diagnostic solution provider, is excited to announce its participation in the ADLM 2024 Clinical Lab Expo (formerly the AACC Clinical Lab Expo).

July 1, 2024
·
1 min read
Drug Development

Novome Biotechnologies Initiates Phase 1/2a Study to Evaluate Therapeutically Engineered Bacteria for the Treatment of Enteric Hyperoxaluria

Novome Biotechnologies, Inc.today announced the start of a Phase 1 clinical trial of NOV-001.

June 30, 2021
·
4 min read
Biotech Bay

Adverum Biotechnologies to Participate in TD Cowen’s Genetic Medicines & RNA Summit

Adverum Biotechnologies, Inc. today announced that Laurent Fischer, M.D., president and chief executive officer of Adverum Biotechnologies, will participate in a fireside chat at TD Cowen’s Genetic Medicines & RNA Summit on Friday, June 21, 2024 at 10:00 a.m. ET.

June 18, 2024
·
1 min read
Press Releases

Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation

Sana Biotechnology, Inc. today highlighted that Nature Biotechnology has published a paper titled “Young glial progenitor cells competitively replace aged and diseased human glia in the adult chimeric mouse brain.”

May 21, 2024
·
6 min read

1 of 12,454

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
Hotbeds
About
More

© 1985 - 2024 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin